Hepatocytes obtained from starved rats were incubated in oxygenated Krebs bicarbonate buffer containing 2% defatted bovine serum albumin. DL-a-Lipoic (dithiooctanoic) acid (1.0mM) caused 
cx-( + )-Lipoic acid (6,8-dithio-octanoic acid) performs a crucial function in oxidative metabolism because it donates the prosthetic (lipoamide) group for the transacylation step in the pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase reactions (Hayakawa et al., 1964) .
There have been reports (Singh & Bowman, 1970; Haugaard & Haugaard, 1970 ) that exogenous lipoic acid accelerates glucose uptake in rat tissues (perfused hearts from normal and alloxandiabetic animals and excised hemidiaphragms from normal rats). This action may be ascribable to a primary reduction of acetyl-CoA levels in these tissues: decrease in acetyl-CoA leads to decrease in citrate levels, activation of phosphofructokinase and hence increased glycolysis (Singh & Bowman, 1970) . In the experiments cited, lipoate also augmented insulin-mediated glucose utilization in rat heart and diaphragm (Singh & Bowman, 1970; Haugaard & Haugaard, 1970) .
The observation that lipoic acid lowers acetylCoA levels in myocardium (Singh & Bowman, 1970) suggested that it might have a similar effect in liver and, consequently, might inhibit hepatic ketogenesis and gluconeogenesis in diabetic rats. In what follows, we present studies of the metabolic effects of lipoic acid in rat liver.
Materials and methods

General considerations
In preliminary experiments it was established that, at concentrations of I.OmM or less, DL-alipoate did not affect either the measurement of acetyl-CoA or the assay of glucose by the glucose oxidase method. It was also ascertained (by measurement of the glycogen content of whole livers after 60min of perfusion with alanine) that there was no net synthesis of glycogen during the period of perfusion in livers from rats starved for 48h. Thus, the glucose which appeared in perfusate (or incubation medium) during the experiments reported below closely approximated the total quantity of glucose synthesized from added C3 precursors.
Animals
Male Sprague-Dawley rats, 100-200g, which had been starved for 48 h were used in these experiments.
Preparation of hepatocytes
Hepatocytes were prepared with collagenase (Sigma) by using published methods (Berry & Friend, 1969 Liver perfusion Livers were perfused for 60min with oxygenated recirculating Krebs bicarbonate buffer (Krebs & Henseleit, 1932) which contained 3% defatted bovine albumin and enough outdated human red blood cells to bring the haematocrit to 20%. Perfusate volume was approx. 80ml. The perfusion technique used in these studies has been previously described (Exton & Park, 1967 (Caraway, 1976) , and glycogen by assay of the glucose liberated by acid hydrolysis (Walaas & Walaas, 1950) . Other metabolites were measured enzymically with a Gilford recording spectrophotometer. These included acetoacetate (Mellanby & Williamson, 1974) , phydroxybutyrate (Williamson & Mellanby, 1974) , ATP (Lamprecht & Trautschold, 1974) , AMP and ADP (Jaworek et al., 1974 ), acetyl-CoA (Decker, 1974 , coenzyme A (Michal & Bergmeyer, 1974) , citrate (Dagley, 1974) , pyruvate (Czok & Lamprecht, 1974) , and lactate (Gutmann & Wahlefeld, 1974 (Exton & Park, 1967 liberated by HC104 was trapped in the centre well, which contained filter paper immersed in KOH. The centre well was then transferred to a vial and counted for radioactivity.
Statistics
Many of our studies involved the use of a control group and at least three different experimental conditions. In order to compare each of these conditions with the control, Dunnett's t test was employed (Winer, 1971) . This test permits a measure of total variance when a control group and two or more experimental groups coexist. When a control group and only one experimental group coexisted, Student's t test was used to compare them.
Results and discussion
Table 1(a) shows that lipoate inhibited glucose synthesis from six individual precursors. In the case of lactate, at least, the degree of inhibition was dose-related over the range 0.1-1 .OmM-lipoate (Table lb) . In-the presence of 1.OmM-lipoate, glucose formation from reduced substrates (lactate and glycerol) was depressed to the same extent as glucose formation from oxidized substrates (pyruvate and dihdyroxyacetone). Table 2 contains two important observations. First, the inhibition of hepatic gluconeogenesis by lipoate was associated with a decrease in ketogenesis and in the molar ratio of fJ-hydroxybutyrate to acetoacetate in the incubation medium (Table  2a) . Secondly, octanoate reversed the antigluconeogenic effect of lipoate in a dose-related manner (Table 2b ). Production of ketone bodies and the 11-hydroxybutyrate: acetoacetate ratio greatly exceeded control values in the presence of octanoate and increased in response to increments in octanoate concentration. These results can be explained if we assume: (1) that lipoate or one of its P-oxidative derivatives, e.g., bisnorlipoate or tetranorlipoate, suppresses endogenous fatty acid oxidation by sequestering intramitochondrial HSCoA in the form of lipoyl-CoA, bisnorlipoylCoA, or tetranorlipoyl-CoA; (2) that octanoate successfully competes with lipoate for HSCoA, thereby reversing its antigluconeogenic and antiketogenic effects. The first of these assumptions is supported by observations that rats and certain bacteria metabolize lipoate by fl-oxidation of the valeric acid side chain (Harrison & McCormick, 1974; Chang et al., 1975; Shih et al., 1975; Spence & McCormick, 1976; Furr et al., 1978) . The second assumption is consistent with the finding that octanoate depressed the oxidation of lipoate in rat liver homogenates (Harrison & McCormick, 1974) .
The data in Table 3 provide more direct evidence that lipoate combines with HSCoA to form lipoyl-CoA and that octanoate opposes this reaction. When livers from starved rats were perfused with lipoate, rapid and sustained decreases occurred in hepatic concentrations of HSCoA and acetyl-CoA (striking changes were apparent at 5 min and persisted for at least 75 min). When perfusion media contained equimolar amounts of lipoate and octanoate, there was an early decline in Table 1 . Effect of lipoate on glucose formation from multiple substrates in hepatocytes from rats starved for 48h (a) Incubations (30min) of hepatocytes were carried out at 370C and pH 7.4 in Krebs bicarbonate buffer containing 2% defatted bovine serum albumin, 0-1.OmM-lipoate, and 5mM concentrations of each of the glucose precursors indicated. ***P<0.001. Glucose production is expressed per g wet wt. of hepatocytes/30min. Each number in parentheses gives the number of observations in a particular subgroup. The inhibitory effects of 1 mM-lipoate were not reversed by 15 Table 7 ), it is likely that lipoate inhibited the two principal pathways of pyruvate disposal, oxidation and carboxylation. We assume that conversion of pyruvate to glucose was impaired at the carboxylation step, because published data suggest that the measured acetyl-CoA concentrations of 0.01-0.02 4umol/g dry wt. (see Table 3 ) would have been insufficient to stimulate pyruvate carboxylase (Utter & Scrutton, 1969; Toews et al., 1970) . On the other hand, the inhibition of pyruvate oxidation by lipoate is not explained by our data. It is unlikely that the 60 65% decrease in hepatic coenzyme A levels induced by lipoate (Table 3) would have interfered with pyruvate decarboxylation (Ngo & Barbeau, 1978) . Depression of pyruvate carboxylase activity does not account for lipoateinduced inhibition of glucose formation from fructose, glycerol and dihydroxyacetone, compounds which enter the gluconeogenic pathway 'distal' to pyruvate decarboxylase.
A reasonable explanation for lipoate-induced inhibition of glucose synthesis from these compounds is that formation of lipoyl-CoA greatly decreased the amount of acetyl-CoA available for citrate synthesis. Consequently, the increments in citrate concentration observed in livers perfused with lactate/lipoate were exceedingly small (see Table 3 ). It is known that citrate inhibits phosphofructokinase and that coenzyme A decreases the concentration of citrate required for such inhibition (Parmeggiani & Bowman, 1963) . In the presence of lipoate, hepatic coenzyme A levels were substantially depressed and thus the highest citrate level attained (0.48 jmol/g dry wt.) was probably inadequate to block enzyme action. As a result, the direction of carbon flux was reversed at the level of fructose 6-phosphate and net glucose synthesis declined.
This conclusion is supported by the studies of Singh & Bowman (1970) . These investigators perfused rat hearts with glucose or glucose and 1.0 mMlipoate and noted with the latter a decrease in citrate concentration (1.595 to 0.795pmol/g dry wt.), increased conversion of glucose to lactate, and a 'crossover' between fructose 6-phosphate and fructose 1,6-bisphosphate consistent with an increase in phosphofructokinase activity. When livers were perfused with lactate/lipoate/octanoate, citrate concentration at 75min was 0.47,mol/g dry wt., i.e., equivalent to the concentration found after perfusion with lactate and lipoate. Yet octanoate clearly reversed lipoate-mediated blockade of gluconeogenesis. These results are compatible with the concept of early stimulation of gluconeogenesis, due to a high rate of octanoate oxidation, and late depression of glucose production, due to octanoate depletion and the unopposed action of lipoate.
Evidence is presented in Table 5 that lipoate antagonizes gluconeogenesis, in part, by augmenting glycolysis. When fructose or glycerol was used as the substrate in hepatocytes from starved rats, lipoate-mediated blockade of glucose synthesis was associated with an increase in lactate production sufficient to account for 30-40% of the inhibitory effect. (Measurement of lactate production underestimates glycolytic rate since pyruvate, the end product of glycolysis, is not only converted to lactate but also oxidized and transaminated to form alanine.) Addition of octanoate to hepatocytes incubated in a mixture of glycerol and lipoate partially relieved the depression in glucose output and concomitantly decreased lactate production. These effects can be attributed to octanoate-induced increases in hepatic acetyl-CoA and citrate levels. The failure of octanoate to restore normal glucose production in these experiments, as well as in studies employing other glucose precursors, is probably related to the continuous removal of octanoate by fl-oxidation during the 30min hepatocyte incubations. As suggested previously, this would lead to progressive intensification ofthe antigluconeogenic action of lipoate. In other words, when lipoate, octanoate, and glycerol are simultaneously added to hepatocyte suspensions, gluconeogenesis is likely to be normal or increased during the first few minutes of incubation, when the effects of octanoate are predominant, but markedly diminished during the latter part of incubation, when the effects of lipoate predominate. This interpretation is consistent with the data in Table 2 on ketone body production in the presence of 1-2mM-octanoate. These data indicate that by the end of the 30 min incubation period, the bulk of added octanoate has undergone partial f-oxidation.
Further evidence that lipoate stimulates glycolysis can be found in the data recorded in Table 6 . When hepatocytes from starved rats were incubated with 5 or 40mM-glucose, the addition of 1 mM-lipoate caused striking increases in lactate production. Table 7 reveals that lipoate did not lower hepatic ATP concentrations or energy charge (Atkinson, 1968) or elevate lactate: pyruvate molar ratios in perfused livers from fasted rats. Maintenance of normal ATP levels under these conditions may be due, in part, to diminished utilization of ATP by energy-requiring processes (e.g., gluconeogenesis or conversion of endogenous fatty acid to fatty acyl-CoA) and to production of ATP by glycolysis.
In conclusion, using multiple glucose precursors, we have shown that lipoic acid powerfully inhibits hepatic gluconeogenesis. This effect appears to be the consequence of a single primary action of the drug, i.e., the sequestration of HSCoA as lipoylCoA. Schematically, the following sequence of events is believed to occur: formation of lipoylCoA causes reduction of HSCoA levels, reduction of acetyl-CoA levels, and hence impairment of citrate synthesis. Consequently, citrate levels do not increase sufficiently to repress phosphofructokinase. Low acetyl-CoA concentrations impair gluconeogenesis by preventing the activation of pyruvate carboxylase. By failing to inhibit phosphofructokinase, low citrate levels reverse gluconeogenic flux. This combination of circumstances (i.e. interference with glucose production and enhancement of glycolysis) tends to cause extreme reduction in net glucose synthesis. Octanoate overcomes the antigluconeogenic action of lipoate by reacting with HSCoA to form octanoyl-CoA, which promptly undergoes oxidation to generate acetyl-CoA (and citrate).
Several hypoglycaemic drugs, notably pent-4-enoate and methylene cyclopropylacetate (a metabolite of hypoglycin), resemble lipoate in that they bind intramitochondrial HSCoA and interfere with hepatic gluconeogenesis (Bressler et al., 1969) . Although these authors ascribe the decrease in new glucose synthesis solely to drug-induced suppression of fatty acid oxidation, the data presented above suggest that pent-4-enoate and hypoglycin may also diminish gluconeogenesis by derepressing phosphofructokinase.
